Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeltje M Batelaan

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
The Journal of Nervous and Mental Disease|June 2, 2012
Mixed anxiety depression should not be included in DSM-5Neeltje M Batelaan, Jan Spijker, Ron de Graaf, et al.
Personality Disorders|August 4, 2022
The impact of borderline personality disorder symptoms on onset and course of anxiety disorders: Results of a general population studyAnne Geluk Rouwhorst, Margreet Ten Have, Ron de Graaf, et al.
The International Journal of Neuropsychopharmacology|July 8, 2011
Evidence-based pharmacotherapy of panic disorder: an updateNeeltje M Batelaan, Anton J L M Van Balkom, Dan J Stein
Pulmonary Circulation|July 22, 2017
Pathways to experiencing mental problems and need for mental support in patients with pulmonary arterial hypertensionAnna D T Muntingh, Sylvia Gerritsen, Neeltje M Batelaan, et al.
Clinical Neuropsychiatry|December 15, 2021
Relieving the Burden of Family Members of Patients with Obsessive-Compulsive DisorderKarin C P Remmerswaal, Neeltje M Batelaan, Anton J L M van Balkom
Psychiatry Research|December 15, 2023
Insomnia and the incidence, recurrence and persistence of common mental disorders: Sex-differences in the general populationAnnemarie I Luik, Judith van der Riet, Neeltje M Batelaan, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 1, 2019
[Relapse in anxiety disorders]Anna D T Muntingh, Neeltje M Batelaan, Anton J L M van Balkom
Journal of Clinical Psychopharmacology|April 10, 2015
Agomelatine as a novel treatment option in panic disorder, results from an 8-week open-label trialKlaas M Huijbregts, Neeltje M Batelaan, Judy Schonenberg, et al.
The Australian and New Zealand Journal of Psychiatry|April 23, 2021
Course trajectories of anxiety disorders: Results from a 6-year follow-up in a general population studySimone Me Schopman, Margreet Ten Have, Anton J van Balkom, et al.
The Australian and New Zealand Journal of Psychiatry|December 4, 2019
A clinical staging approach to improving diagnostics in anxiety disorders: Is it the way to go?Wicher A Bokma, Neeltje M Batelaan, Adriaan W Hoogendoorn, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Nervous and Mental Disease|June 2, 2012
Mixed anxiety depression should not be included in DSM-5Neeltje M Batelaan, Jan Spijker, Ron de Graaf, et al.
Personality Disorders|August 4, 2022
The impact of borderline personality disorder symptoms on onset and course of anxiety disorders: Results of a general population studyAnne Geluk Rouwhorst, Margreet Ten Have, Ron de Graaf, et al.
The International Journal of Neuropsychopharmacology|July 8, 2011
Evidence-based pharmacotherapy of panic disorder: an updateNeeltje M Batelaan, Anton J L M Van Balkom, Dan J Stein
Pulmonary Circulation|July 22, 2017
Pathways to experiencing mental problems and need for mental support in patients with pulmonary arterial hypertensionAnna D T Muntingh, Sylvia Gerritsen, Neeltje M Batelaan, et al.
Clinical Neuropsychiatry|December 15, 2021
Relieving the Burden of Family Members of Patients with Obsessive-Compulsive DisorderKarin C P Remmerswaal, Neeltje M Batelaan, Anton J L M van Balkom
Psychiatry Research|December 15, 2023
Insomnia and the incidence, recurrence and persistence of common mental disorders: Sex-differences in the general populationAnnemarie I Luik, Judith van der Riet, Neeltje M Batelaan, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 1, 2019
[Relapse in anxiety disorders]Anna D T Muntingh, Neeltje M Batelaan, Anton J L M van Balkom
Journal of Clinical Psychopharmacology|April 10, 2015
Agomelatine as a novel treatment option in panic disorder, results from an 8-week open-label trialKlaas M Huijbregts, Neeltje M Batelaan, Judy Schonenberg, et al.
The Australian and New Zealand Journal of Psychiatry|April 23, 2021
Course trajectories of anxiety disorders: Results from a 6-year follow-up in a general population studySimone Me Schopman, Margreet Ten Have, Anton J van Balkom, et al.
The Australian and New Zealand Journal of Psychiatry|December 4, 2019
A clinical staging approach to improving diagnostics in anxiety disorders: Is it the way to go?Wicher A Bokma, Neeltje M Batelaan, Adriaan W Hoogendoorn, et al.
Pageof 9